Cat.#: ACPP-1220
| Despition | ELOVL4 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1437 | Human LINGO1 Protein (AC1437) | 5 µg | inquiry |
| ACPP-1527 | Mouse ANTXR2 Protein (AC1527) | 1 µg | inquiry |
| ACPP-1079 | Dopamine Receptor D1 Blocking Peptide (AC1079) | 250 µg | inquiry |
| ACPP-1827 | Human NHLH2 Protein (AC1827) | 2 µg | inquiry |
| ACPP-1167 | Recombinant Human CD133 Protein (Fc Tag) (AC1167) | 50 µg | inquiry |
| ACPP-1389 | AHSG (AC1389) | 10 µg | inquiry |
| ACPP-1344 | Olig2 Blocking Peptide (AC1344) | 250 µg | inquiry |
| ACPP-1549 | Human VEGF C Protein (AC1549) | 2 µg | inquiry |
| ACPP-1031 | Recombinant Human CD24 Protein (Fc Tag) (AC1031) | 50 µg | inquiry |
| ACPP-1081 | Human NRN1 Protein (AC1081) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.